關於 biosimilar中文 ，我們在網路上蒐集到這些相關的討論、資訊與評價

#11. 美國醫療法規學會(RAPS)台灣分會

但Biosimilar的命名持續地被辯論著： FDA要求bio-equivalent，但biosimilar不只在製程、結構或是bio-equivalent上都有可能因微小不同造成影響。

#12. 論生物相似性藥品上市審查規範：以美國生物藥品價格競爭與 ...

On Regulation of Biosimilar: A Model or a Lesson by the U.S. Biologics ... 中文摘要：, 2010 年 10 月 23 日美國歐巴馬政府簽署公告「生物藥品價格競爭與創新 ...

#13. biosimilar medicines - 英中– Linguee词典

大量翻译例句关于"biosimilar medicines" – 英中词典以及8百万条中文译文例句搜索。

#14. 台灣生物相似性藥品在上市後之使用評估

論文名稱(外文):, Evaluation of the Biosimilar Drug Utilization after Marketed ... 語文別: 中文 ... Biosimilar drugs have made breakthroughs in recent years.

#15. 台康生技的乳癌生物相似藥(EG12014, A TRASTUZUMAB ...

台康生技的乳癌生物相似藥(EG12014, a Trastuzumab Biosimilar candidate)三期臨床試驗期中分析報告已於2021年聖安東尼奧乳...

#16. TSY-0110 Kadcyla ® 生物相似藥

人才招募 · 聯絡我們; 中文. Menu Toggle. English · 台新藥股份有限公司. Main Menu ... 人才招募 · 聯絡我們; 中文. Menu Toggle. English. 台新藥研發專案 ...

#17. Anti-SARS-CoV-2 Spike RBD (CB6 biosimilar) Neutralizing ...

Anti-SARS-CoV-2 Spike RBD (CB6 biosimilar) Neutralizing Antibody Immobilized Recombinant SARS-CoV-2 Spike Protein (RBD, C-mFc Tag)(Active) at 2.0 ug/mL(100 ...

#18. Biosimilar medicines - Multistakeholder Event (13 December ...

News announcement19 October 2022Directorate-General for Health and Food Safety. Biosimilar medicines - Multistakeholder Event (13 December 2022).

#19. 生物相似性藥品 - 衛生福利部中央健康保險署

... [開啟新連結] · 健保收載之生物相似性藥品_1111128.ods[開啟新連結]; 生物相似性藥品健保給付問答集 Biosimilar QA.pdf[開啟新連結]; 相關網站連結.

#20. 生物相似藥的展望

Biosimilar 的定義(生物相似藥). •Biosimilar是一個大分子的生物製劑藥物(biological medicine)，並與已上市核准的生物製劑 ... Trazimera 中文仿單MOH 20181210-2.

#21. 生物相似藥的市場行銷策略 - 臺灣聯合大學博碩士論文系統

論文名稱(外文):, The Marketing Strategy of Biosimilar. 指導教授: 李光申 ... 中文關鍵詞: 生物相似藥. 外文關鍵詞: biosimilar. 相關次數:.

#22. Biosimilar Candidate 生物類似藥候選人

A randomized phase-I pharmacokinetic trial comparing the potential biosimilar tocilizumab (QX003S) with the reference product (Actemra®) in Chinese healthy ...

#23. ELISA Kits for Therapeutic & Biosimilar Antibodies - 伯森生技

Monoclonal therapeutic antibodies & biosimilars. 單株抗體藥物是利用抗體的專一性標的攻擊特定細胞或蛋白質，目前已成功應用在諸如癌症與阿茲海 ...

#24. 醫藥品上市審查規範與專利權保護之研究-從學名藥到生物相似 ...

參考文獻: 一、中文資料 (一)中文專書 ... Genazzani, A.A. et al., Biosimilar drugs: concerns and opportunities, 21 BioDrugs : clinical immunotherapeutics, ...

#25. 【一週國際法規新聞】2022 年09月19日~ 09月23日

詳細內容請看：Europe: Biosimilar medicines can be interchanged. 歐洲：瑞士Swissmedic更新亞硝胺不純物的處理規範針對藥品中亞硝胺不純物的處理 ...

#26. Guidelines on evaluation of biosimilars

On the basis of proven similarity, the licensing of a biosimilar would in part ... national regulatory frameworks for the licensure of such biosimilars.

#27. 《生技防身術》: 投資生物相似藥基本功 - Genet觀點

因此，某一新的生物藥品上市若干年後，其專利失效後，該仿製品即稱為「生物相似藥(Biosimilar)」。 由於生物製劑的研發與製程較化學製劑更複雜，進入 ...

#28. Methodologies in Biosimilar Product Development - 博客來

書名：Methodologies in Biosimilar Product Development，語言：英文，ISBN：9780367896348，頁數：440，出版日期：2021/09/24，類別：自然科普.

#29. Malaysian Hospital Pharmacists' Perspectives and Their Role ...

Background With the increasing availability biosimilars, ... Although Malaysian pharmacists are in favour of biosimilars, ... 中文翻译： ...

#30. 生物相似性藥品商機觀察從全球發展看台灣機會 - Deloitte

TW-ZH 國家／地區: Taiwan-Chinese. TW-ZH 國家／地區: Taiwan-Chinese. 中文 |; English. Biosimilars in global markets. 議題觀點 ...

#31. Biosimilars - Waters Corporation

Regulatory agencies have provided paths for submitting applications for biosimilars. Waters offers analytical and informatics technologies to define the ...

#32. Biosimilar Antibodies | Bio-Techne

United States - (简体中文). 国家/地区选择. Please enter your country/region. ... Our biosimilar antibodies are great tools for drug research studies.

#33. What are Biosimilars? | Fight Colorectal Cancer

In this biosimilars video, we explain what a biosimilar drug is, approved biosimilars for colorectal cancer patients and questions to discuss with your ...

#34. Update on Biosimilars — Complexity of Biologics and Clinical ...

monitoring of biosimilars will be reviewed. Key Words: Biosimilar pharmaceuticals; Drug approval; Pharmacovigilance. 中文摘要.

#35. Biocon Biologics - LinkedIn

It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases.

#36. 2022/3/26(六)【醫藥法規系列】生物藥開發之CMC法規要求及 ...

Experience from early stage of research and development to receiving BLA 351(k) Biosimilar Application. 3. 針對生物藥與主管機關諮詢會議BLA Regulatory ...

#37. Biosimilar Products Provide Additional Options for Medical Care

Biosimilar product is one of the fast-growing types of medicine in the global pharmaceutical market. Increasing the accessibility of ...

#38. Biosimilar medicines and cost-effectiveness | CEOR

Steven Simoens Research Centre for Pharmaceutical Care and Pharmaco-economics, Faculty of Pharmaceutical Sciences, Katholieke Universiteit ...

#39. Understanding Biosimilars | Pfizer Canada

What is a biosimilar? A biosimilar biologic product is a biologic medicine authorized for sale based on demonstrating that it is highly similar to a ...

#40. Biosimilar 释义| 柯林斯英语词典

Biosimilar 释义: a biological medicine which exhibits no clinically meaningful difference from another... | 意思、发音、翻译及示例.

#41. News-Adimmune Completes Process Development with SCD ...

Adimmune Corporation announced the completion of the process development with SCD for the biosimilar to Eylea, a novel intravitreal ...

#42. Cultivating a vibrant U.S. market for biosimilars - Brookings

Cultivating a vibrant U.S. market for biosimilars: A conversation with FDA's Scott Gottlieb. Co-hosted by the USC-Brookings Schaeffer ...

#43. Biosimilars Development and Testing - Sartorius

Biosimilar Targets · Biosimilar Testing Services · Work With the Leading Experts · Biosimilar Development Services · Biosimilar Cell Line Development.

#44. State laws for biosimilar interchangeability - Cardinal Health

Cardinal Health has partnered with our regulatory advisors to develop a resource to help pharmacists understand state-specific biosimilar interchangeability ...

#45. DIA DEEP DIVE: Biosimilars Spending

首次访问？ 浏览成为会员后将享受的福利。 成为会员. language Language: 中文. 当前： 中文.

#46. 銀屑病與生物仿製劑

版權俱屬香港中文大學藥劑學院及. 講者所有。未經允許,不得複製全部或任何部分。 生物仿製劑(Biosimilar). • 生物相似製劑. • 生物製劑大多為蛋白質.

#47. Biotechnology and Pharmaceutical Plant Engineering - 中宇環保

Name：, Biosimilar Drug Facility Construction Project. Location：, Hsinchu, Taiwan. Date of Completion：, 2018.03. Scope of Work：, MEP Design, Procurement, ...

#48. 全球藥霸Humira 迎戰生物相似藥美歐市場穩如泰山？ - 基因線上

3. https://www.fiercepharma.com/pharma/aggressive-eu-embrace-biosimilars-may-pose-a-bigger-threat-to-humira-than-abbvie-lets.

#49. Biosimilar biological products - Glossary - HealthCare.gov

中文 · Kreyòl · Français · Deutsch · ગુજરાતી · हिंदी · Italiano · 日本語 · 한국어 · Polski · Português · Русский · Español · Tagalog ...

#50. 研發策略| 安進台灣

中文 品名: 安捷達注射液英文品名: AMGEVITA Solution for Injection 主成分: adalimumab 許可證字號: 衛部菌疫輸字第001098號適應症: ...

#51. Australian Government embarks on push for growth of ...

Approval and use of biosimilar medicines in Australia is set to grow in the wake of changes affecting registration and market uptake of ...

#52. The Cost Savings Potential of Biosimilar Drugs in the United ...

The U.S. Food and Drug Administration is expected to release regulations outlining lower-cost approval requirements for so-called biosimilar ...

#53. Biosimilars Virtual Conference Session 1: Barriers to Uptake ...

首次访问？ 浏览成为会员后将享受的福利。 成为会员. language Language: 中文. 当前： 中文.

#54. News - Synermore Biologics

Synermore is a Taiwan based biotech company focused on the research and development of innovative and biosimilar monoclonal antibodies in the areas of ...

#55. 中国获批的生物类似药| Approved Biosimilars in China

Biosimilar 生物类似药 Applicant 申请人 Ref. Product 参考药品 NMPA App... HLX01 汉利康® Henlius 复宏汉霖 RITUXAN® (rituximab) 2019‑02‑22 BAT1406 格乐立® Bio‑Thera Solutions 百奥泰生物 HUMIRA® (adalimumab) 2019‑11‑04 HS016 安健宁® Zhejiang Hisun 海正生物 HUMIRA® (adalimumab) 2019‑12‑06

#56. BIOSIMILAR 中文是什么意思- 中文翻译 - Tr-ex

山德士致力于促进生物仿制药竞争，提供高质量、低成本的药物，并为更可持续的医疗体系做出贡献。 Positive CHMP opinion for biosimilar ABP 980 for the treatment of ...

#57. RPT-UPDATE 3-FDA rejects Coherus's biosimilar for Neulasta ...

Coherus BioSciences Inc said on Monday the U.S. Food and Drug Administration (FDA) declined to approve its biosimilar copy of Amgen Inc's ...

#58. A positive step forward for Biosimilar registration - ELC Group

Currently, to obtain a marketing authorisation for a biosimilar, ... 激活策略及审计趋势”的中文线上讲座，为各位同仁分享我们的GMP审计经验，欢迎大家报名参与！

#59. 2021 Taipei Biotech Awards

Go-Global Award > Gold Medal Award · Subject. Global Market of EG12014 Herceptin Biosimilar for HER2-Positive Breast Cancer and CDMO Service · Unit. EirGenix, Inc ...

#60. Biosimilars | AmerisourceBergen - World Courier

At AmerisourceBergen, we believe in the promise of biosimilars to deliver cost savings across healthcare. We also understand the potential hurdles these ...

#61. Biosimilar drugs may help fight prescription drug costs

What is a biosimilar drug and how does it compare to a biologic? Find the answer here, plus how they may help save on prescription drug costs.

#62. Incentivizing Generic and Biosimilar Product Uptake | ASPE

Once a drug comes off patent, the U.S. has been highly successful in reducing prices and improving the value received by promoting generic drug introduction ...

#63. What are Biosimilars | Evernorth

What are biosimilars? A biosimilar is a specific type of biologic drug. Biologics are powerful therapies derived from living organisms, such as ...

#64. 135 Biosimilar Images, Stock Photos & Vectors - Shutterstock

Find Biosimilar stock images in HD and millions of other royalty-free stock photos, illustrations and vectors in the Shutterstock collection.

#65. BioVeda China Fund (BVCF)

The capital raised in this round will help accelerate the clinical development of multiple innovative biologics and biosimilars in Boan Biotech's pipeline, ...

#66. Optimizing a Biosimilar Production Process - Eppendorf 艾本德

The objective of the research project presented in this webinar was to determine if the three primary methods of production for a typical biosimilar may be ...

#67. Life Sciences Biosimilar Testing Services

Biosimilar development is unlike that of a novel biotherapeutic or generic drug, which is why you need accurate analysis at every stage.

#68. Introduction to Biologic and Biosimilar Product Development ...

Introduction to Biologic and Biosimilar Product Development and Analysis - 醫療保健, Karen M. Nagel, 9783319984285.

#69. Annex 1 Revision, FDA Biosimilar Workshop & More - NSF

The September update: NSF provides a comprehensive look at the Annex 1 revision, FDA Biosimilar Workshop, EMA Concept, and more.

#70. Celltrion presents data on Remsima interchangeability ...

Celltrion presents data on Remsima interchangeability, resumes Rituxan biosimilar development. Published: 04 November 2013. South Korea-based firm Celltrion ...

#71. 台康生技股份有限公司 - BIO Asia-Taiwan

Biosimilar Business: EirGenix currently has seven products undergoing development. Four antibody products are for treating HER2 gene variance; one antibody ...

#72. Lisa Taliadoros | 團隊 | 繁體中文 - Jones Day

... relating to patents for new compounds, biologics, biosimilars, drug formulations, drug delivery devices, dental technology, and methods of treatment.

#73. Generic and Biosimilar - Medications - National MS Society

Generic, biologic and biosimilar are all terms for non-brand medications (also known as a drug or therapy) determined by the US Food and Drug Administration ...

#74. Biosimilar Drug Development | Services - ICON plc

Biosimilars · As the number of biologics going off-patent increases, biosimilar medicines are attractive to healthcare organisations, physicians, and patients by ...

#75. FDA approves of biosimilar to infliximab — IBD in the news

The FDA recently approved a biosimilar (CT-P13) to infliximab, which is used for treating IBD, as well as people with rheumatoid arthritis ...

#76. Celltrion chairman vows to help his company become world ...

"By 2030, 60 percent of our annual sales will come from biosimilar medicine and 40 percent from new original drugs," he said in an online ...

#77. 生物相似性藥品專區 - 衛生福利部食品藥物管理署

生物相似性藥品為與我國核准之原開發廠商之生物藥品(或參考藥品)高度相似之生物製劑，於品質、安全、療效與參考藥品無臨床上有意義的差異(no ...

#78. National Center for Biotechnology Information

Welcome to NCBI ... The National Center for Biotechnology Information advances science and health by providing access to biomedical and genomic information. About ...

#79. Henlius 2022 Annual Results: Significant Achievements in ...

Driven by our self-developed biosimilars and innovative products, we will continue to enhance our market competitiveness for a higher-level ...

#80. California's Plan for Cheaper Insulin Collides With Big ...

The biosimilar versions are expected to be comparable to Eli Lilly's Humalog, Novo Nordisk's NovoLog and Sanofi's Lantus. These three companies ...

#81. CMS Issues Initial Guidance on Medicare Drug Price ...

... must be high-expenditure, single-source drugs, meaning drugs for which there is no generic or biosimilar competition, and they must:.

#82. Forms for health care professionals - Aetna

For language services, please call the number on your member ID card and request an operator. For other language services: Español-Spanish | 中文 | Tiếng Việt | ...

#83. Chief Pharmacist Explains New Class of Drugs - atteru.online

... preferred language English عربى 简体中文 繁體中文 فارسي עִברִית ... The new drugs, known as biosimilars, are essentially equivalent to ...

#84. Business Roundup - C&EN - American Chemical Society

Sandoz says it will spend $400 million building a plant in Slovenia making biosimilar drugs, a field where Sandoz wants to be the leader.

#85. Chief Pharmacist Explains New Class of Drugs - Artictle

... Close Select your preferred language English عربى 简体中文 繁體中文 فارسي ... Health insurers have specified which brands or biosimilar medications that ...

#86. We are WSP in Canada - WSP

中文 (简体) - English. Hong Kong ... A state-of-the-art facility for developing challenging but vital “biosimilar” treatments.

#87. 6 analyst picks: Lululemon sparkles | Pro Recap - Investing.com

“Through its multiple biosimilar launches, Coherus has multiple shots on goal; we believe biosimilar revenue can climb to $580m by '25E ...

#88. Chief Pharmacist Explains New Class of Drugs

... language English عربى 简体中文 繁體中文 فارسي עִברִית 日本語 한국어 Рус. ... The new drugs, known as biosimilars, are essentially equivalent to ...

#89. Henlius 2022 Annual Results: S - GuruFocus.com

Driven by our self-developed biosimilars and innovative products, we will continue to enhance our market competitiveness for a higher-level ...

#90. BioNTech is ripe for a rebound in 2023 - FXStreet

AbbVie (NYE:ABBV) and Merck (NYSE:MRK) are already struggling with biosimilar compounds competing with Humira and Januvia, and others, ...

#91. Lab Members Bilsborough Lab Cedars Sinai - 2023

Lab Members - Bilsborough Lab Cedars-Sinai Skip to content Close Select your preferred language English عربى 简体中文 繁體中文 فارسي עִברִית 日本語 한국어 ...

#92. expicho - Frantoio Fratelli Amodio

Biosimilar antibody development 3. A3711001). ... The application's main feature is a real-time PCR handbook covering all ExpiCHO操作手册-中文-2018版.

#93. 0214 mitbbs - notizieperte.it

未名空间（mitbbs）是同时使用中文和英文，并以中文为主的bbs网站。 ... a proposed biosimilar of Enbrel (etanercept), met its primary endpoints in a Phase 3 ...

#94. FOX 11 Dr Zuri Murrell Discusses New Recommendations for ...

... Discusses New Recommendations for Colon Cancer Screening Skip to main content Close Select your preferred language English عربى 简体中文 繁體中文 فارسي ...

#95. Orthopaedic Experts Show Teenage Girls How to Avoid Knee ...

... How to Avoid Knee Injuries Skip to main content Close Select your preferred language English عربى 简体中文 繁體中文 فارسي עִברִית 日本 ...

#96. 生物相似性藥品之臨床應用以癌症治療為例

Biosimilars 101: considerations for U.S. oncologists in clinical practice. Cancer Med. 2014;3(4):889–899. 2. Van de Vooren K, Curto A, Garattini L. Biosimilar ...